254 related articles for article (PubMed ID: 1697368)
1. Angiotensin-converting enzyme inhibitors and the kallikrein-kinin system.
Shimamoto K; Matsuki T; Iimura O
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S83-90. PubMed ID: 1697368
[TBL] [Abstract][Full Text] [Related]
2. Activation of kinins on myocardial ischemia.
Shimamoto K; Miura T; Miki T; Iimura O
Agents Actions Suppl; 1992; 38 ( Pt 3)():90-7. PubMed ID: 1462887
[TBL] [Abstract][Full Text] [Related]
3. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
4. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
5. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
Iimura O; Shimamoto K
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107
[TBL] [Abstract][Full Text] [Related]
6. Kinin-related effects of angiotensin-converting enzyme inhibition.
Bönner G
Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
[TBL] [Abstract][Full Text] [Related]
7. Kinin- and non-kinin-mediated interactions of converting enzyme inhibitors with vasoactive hormones.
Kramer HJ; Glänzer K; Meyer-Lehnert H; Mohaupt M; Predel HG
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S91-8. PubMed ID: 1697369
[TBL] [Abstract][Full Text] [Related]
8. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
9. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the mechanism of action of angiotensin converting enzyme inhibitors on the dog kidney].
Omosu M
Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):883-94. PubMed ID: 1484407
[TBL] [Abstract][Full Text] [Related]
11. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
[TBL] [Abstract][Full Text] [Related]
12. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
13. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
14. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
Burnier M; Brunner HR
Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
[TBL] [Abstract][Full Text] [Related]
15. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
16. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
Bönner G
Z Kardiol; 1988; 77 Suppl 3():23-7. PubMed ID: 3062958
[TBL] [Abstract][Full Text] [Related]
17. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
Uehara Y; Hirawa N; Numabe A; Kawabata Y; Ikeda T; Gomi T; Gotoh A; Omata M
Am J Hypertens; 1997 May; 10(5 Pt 2):83S-88S. PubMed ID: 9160787
[TBL] [Abstract][Full Text] [Related]
18. Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.
Tanaka S; Shimamoto K; Ando T; Nakahashi Y; Ura N; Hosoda S; Ishida H; Yamaji I; Yokoyama T; Masuda A
Clin Exp Hypertens A; 1987; 9(2-3):605-9. PubMed ID: 3038424
[TBL] [Abstract][Full Text] [Related]
19. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
